Colgate-Palmolive (NYSE:CL) Shares Sold by Range Financial Group LLC

Range Financial Group LLC decreased its position in shares of Colgate-Palmolive (NYSE:CLFree Report) by 2.1% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 10,388 shares of the company’s stock after selling 226 shares during the quarter. Range Financial Group LLC’s holdings in Colgate-Palmolive were worth $828,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Moneta Group Investment Advisors LLC increased its holdings in shares of Colgate-Palmolive by 90,253.2% in the 4th quarter. Moneta Group Investment Advisors LLC now owns 15,974,451 shares of the company’s stock valued at $1,258,627,000 after acquiring an additional 15,956,771 shares during the period. Norges Bank purchased a new stake in shares of Colgate-Palmolive in the fourth quarter valued at approximately $644,715,000. Renaissance Technologies LLC boosted its holdings in Colgate-Palmolive by 151.6% during the first quarter. Renaissance Technologies LLC now owns 5,688,786 shares of the company’s stock worth $431,381,000 after buying an additional 3,427,400 shares in the last quarter. Morgan Stanley boosted its stake in shares of Colgate-Palmolive by 41.7% during the 4th quarter. Morgan Stanley now owns 11,370,549 shares of the company’s stock worth $895,886,000 after acquiring an additional 3,345,297 shares in the last quarter. Finally, Caisse DE Depot ET Placement DU Quebec grew its stake in Colgate-Palmolive by 1,915.2% in the 1st quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,793,287 shares of the company’s stock valued at $135,985,000 after acquiring an additional 1,704,300 shares during the last quarter. Hedge funds and other institutional investors own 78.36% of the company’s stock.

Colgate-Palmolive Trading Down 0.2 %

Shares of CL stock opened at $88.30 on Monday. The company has a quick ratio of 0.71, a current ratio of 1.11 and a debt-to-equity ratio of 8.59. Colgate-Palmolive has a fifty-two week low of $67.62 and a fifty-two week high of $89.36. The firm’s 50 day moving average price is $84.22 and its two-hundred day moving average price is $78.21. The stock has a market cap of $72.68 billion, a price-to-earnings ratio of 31.82, a price-to-earnings-growth ratio of 3.40 and a beta of 0.42.

Colgate-Palmolive (NYSE:CLGet Free Report) last released its quarterly earnings data on Friday, January 26th. The company reported $0.87 EPS for the quarter, beating the consensus estimate of $0.85 by $0.02. Colgate-Palmolive had a return on equity of 509.75% and a net margin of 11.82%. The company had revenue of $4.95 billion for the quarter, compared to analyst estimates of $4.89 billion. During the same period last year, the company posted $0.77 earnings per share. The firm’s revenue was up 6.9% compared to the same quarter last year. On average, analysts anticipate that Colgate-Palmolive will post 3.48 EPS for the current year.

Colgate-Palmolive Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 15th. Stockholders of record on Monday, April 22nd will be paid a dividend of $0.50 per share. The ex-dividend date of this dividend is Friday, April 19th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. This is a positive change from Colgate-Palmolive’s previous quarterly dividend of $0.48. Colgate-Palmolive’s dividend payout ratio (DPR) is currently 69.06%.

Wall Street Analyst Weigh In

Several research analysts recently issued reports on the company. TheStreet upgraded Colgate-Palmolive from a “c+” rating to a “b+” rating in a research report on Friday, January 26th. Bank of America upgraded Colgate-Palmolive from a “neutral” rating to a “buy” rating and set a $90.00 price objective on the stock in a research report on Friday, December 15th. Morgan Stanley upped their target price on shares of Colgate-Palmolive from $85.00 to $93.00 and gave the company an “overweight” rating in a report on Monday, January 29th. Wells Fargo & Company upped their price objective on shares of Colgate-Palmolive from $80.00 to $88.00 and gave the company an “equal weight” rating in a research note on Monday, January 29th. Finally, Raymond James raised Colgate-Palmolive from a “market perform” rating to an “outperform” rating and set a $91.00 price target on the stock in a research note on Monday, January 29th. Three analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $87.31.

Get Our Latest Research Report on Colgate-Palmolive

Insider Transactions at Colgate-Palmolive

In related news, EVP Gregory Malcolm sold 8,930 shares of Colgate-Palmolive stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total transaction of $762,175.50. Following the sale, the executive vice president now owns 8,043 shares of the company’s stock, valued at approximately $686,470.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. In related news, CEO Noel R. Wallace sold 29,772 shares of Colgate-Palmolive stock in a transaction on Friday, February 16th. The shares were sold at an average price of $84.06, for a total value of $2,502,634.32. Following the completion of the sale, the chief executive officer now owns 301,343 shares in the company, valued at $25,330,892.58. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Gregory Malcolm sold 8,930 shares of the company’s stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $85.35, for a total transaction of $762,175.50. Following the completion of the sale, the executive vice president now directly owns 8,043 shares in the company, valued at $686,470.05. The disclosure for this sale can be found here. Over the last three months, insiders have sold 232,371 shares of company stock valued at $19,505,099. Corporate insiders own 0.34% of the company’s stock.

Colgate-Palmolive Profile

(Free Report)

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.

Featured Stories

Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CLFree Report).

Institutional Ownership by Quarter for Colgate-Palmolive (NYSE:CL)

Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.